Compassionate access opens for MS patients with no other options
NCT ID NCT04540861
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 17 times
Summary
This program provides siponimod, a medication that helps control disease activity, to adults with secondary progressive multiple sclerosis who have no satisfactory alternative treatments. Patients must have active disease and a doctor's request. The goal is to manage the condition, not cure it, and ongoing treatment is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.